MD Anderson Cancer Center Gastroenterology
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bresalier, Robert S
NCT02521285: Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

Active, not recruiting
2
21
Canada, US
Aspirin, Acetylsalicylic Acid, ASA, Aspergum, Ecotrin, Empirin, Entericin, Extren, Measurin, Laboratory Biomarker Analysis, Placebo Administration, Questionnaire Administration
National Cancer Institute (NCI)
Barrett Esophagus
06/19
03/25
ECLIPSE, NCT04136002: Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

Active, not recruiting
N/A
44467
US
Guardant Health, Inc., Premier Research Group plc
Colorectal Cancer
06/24
12/25
NCT00843375: Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Recruiting
N/A
1200
Canada, US, RoW
University of Michigan Rogel Cancer Center, Early Detection Research Network, Clinical Genomics Pathology, VolitionRx, Department of Health and Human Services, Great Lakes New England Clinical Validation Center, National Cancer Institute (NCI)
Colonic Neoplasms
03/28
03/28
Tipps, Tamara
ECLIPSE, NCT04136002: Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

Active, not recruiting
N/A
44467
US
Guardant Health, Inc., Premier Research Group plc
Colorectal Cancer
06/24
12/25

Download Options